IRIS
COSTA, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 948
NA - Nord America 746
AS - Asia 94
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.790
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 745
IE - Irlanda 405
SE - Svezia 220
IT - Italia 165
CN - Cina 71
PL - Polonia 40
DE - Germania 31
FI - Finlandia 20
IN - India 15
BE - Belgio 14
GB - Regno Unito 14
AT - Austria 13
RU - Federazione Russa 9
FR - Francia 5
UA - Ucraina 5
VN - Vietnam 4
HK - Hong Kong 3
CZ - Repubblica Ceca 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CA - Canada 1
CH - Svizzera 1
ES - Italia 1
EU - Europa 1
HR - Croazia 1
NL - Olanda 1
RO - Romania 1
TR - Turchia 1
Totale 1.790
Salva come PNG Salva come JPEG
Città #
Dublin 405
Chandler 186
Nyköping 165
Ashburn 79
Messina 46
Warsaw 40
Dearborn 31
Bremen 26
Princeton 26
Ann Arbor 25
Jacksonville 25
Medford 23
Des Moines 22
Beijing 20
New York 20
Rome 19
Phoenix 16
Brussels 14
Vienna 13
Cambridge 10
Pune 9
Catania 8
Houston 8
Milan 8
Nanjing 8
Boardman 7
Guangzhou 7
Hyderabad 6
San Mateo 6
Haikou 5
Jinan 5
London 5
Cagliari 4
Carrara 4
Dong Ket 4
Hebei 4
Washington 4
Wilmington 4
Chicago 3
Fairfield 3
Hangzhou 3
Shenyang 3
Woodbridge 3
Bardolino 2
Bologna 2
Enna 2
Helsinki 2
Jiaxing 2
Kemerovo 2
Perugia 2
Piazza Armerina 2
Polignano A Mare 2
Seattle 2
Taizhou 2
Wuhan 2
Aci Sant'antonio 1
Albuquerque 1
Antalya 1
Auburn Hills 1
Barnstaple 1
Biancavilla 1
Carini 1
Changsha 1
Chengdu 1
Córdoba 1
Edinburgh 1
Florence 1
Floridia 1
Galati 1
Gatchina 1
Lachine 1
Lamézia 1
Lancaster 1
Los Angeles 1
Mcallen 1
Moscow 1
Nanning 1
Ningbo 1
Nizhniy Novgorod 1
Norwalk 1
Nuremberg 1
Perm 1
Pisa 1
Portofino 1
Prague 1
Ramacca 1
Rotterdam 1
Shenzhen 1
Taiyuan 1
Tappahannock 1
Tianjin 1
Trecastagni 1
Viagrande 1
Villafranca Tirrena 1
Voronezh 1
Zagreb 1
Zhengzhou 1
Totale 1.398
Salva come PNG Salva come JPEG
Nome #
Impellent impeller-Switching intra-aortic balloon pump to IMPELLA-CP after ST-segment elevation myocardial infarction and refractory cardiogenic shock 87
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial 84
Appraising the counter-balancing ischemia and bleeding risks for dual antiplatelet therapy duration after coronary stenting 78
Correlations between genetic mutations, biomolecular patterns and elastic properties of the aorta in patients with bicuspid aortic valve. 70
Obstructive sleep apnoea syndrome and endothelial function: potential impact of different treatment strategies-meta-analysis of prospective studies 69
Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: Results of an EAPCI survey 67
Elastin and aortopathy in bicuspid aortic valve: correlations between genetic and biomolecular patterns and mechanical properties of the aorta 62
Radial Artery Access for Percutaneous Cardiovascular Interventions: Contemporary Insights and Novel Approaches 60
P1468Non-invasive myocardial work indices in ischemic heart disease 58
A meta-analysis of 22108 patients undergoing PCI: can radial approach reduce the incidence of acute kidney injury? 56
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 53
686 Coronary lesion distribution in young patient presenting with acute coronary syndrome 50
Fibrosis after Myocardial Infarction: An Overview on Cellular Processes, Molecular Pathways, Clinical Evaluation and Prognostic Value 48
Benefit of radial approach in reducing the incidence of acute kidney injury after percutaneous coronary intervention: A meta-analysis of 22,108 patients 47
Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials 46
Left Main Coronary Artery 45
Impact of a 24- rather than 6-month dual antiplatelet therapy with clopidogrel in patients with left main or proximal left anterior descending coronary artery disease. A post hoc analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent ­Induced Intimal Hyperplasia) PRODIGY trial 42
Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways 42
Impact of vascular access on acute kidney injury after percutaneous coronary intervention 40
752 Acute coronary syndrome in young patients: long-term follow-up and quality of life assessment 40
New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress 40
Incremental Value of the CRUSADE, ACUITY, and HAS-BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy 33
57 ISCHEMIC HEART SCOMBROID SYNDROME: FURTHER EVIDENCE FROM ALL OVER THE WORLD 31
Alcohol septal ablation: An option on the rise in hypertrophic obstructive cardiomyopathy 30
Bleeding risk stratification in acute coronary syndromes. Is it still valid in the era of the radial approach? 29
null 28
Exploring the Incremental Value of CRUSADE Score as Clinical Guidance for the Decision-Making of Dual Antiplatelet Therapy Duration: A Retrospective Analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) PRODIGY Trial Pathway 27
Antithrombotic therapy for percutaneous cardiovascular interventions: From coronary artery disease to structural heart interventions 26
Impact of COVID-19 pandemic on in-hospital outcomes for patients with acute coronary syndrome: a propensity-weighted, multicentre study 21
Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease 20
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations 20
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 20
Distribution of wall motion abnormalities in young patients presenting with acute coronary syndrome 19
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 19
The High Bleeding Risk Patient with Coronary Artery Disease 19
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 19
Off-Target Effects of P2Y12 Receptor Inhibitors: Focus on Early Myocardial Fibrosis Modulation 19
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions 18
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions 17
Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis 17
Anatomic Characteristics and Clinical Implications of Angiographic Coronary Thrombus 17
Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI 17
Chest Pain and the Dynamic Evolution of Spontaneous Coronary Artery Hematoma 16
ELECTRICAL STORM IN ISCHAEMIC HEART DISEASE: A CASE OF LEFT STELLATE GANGLION BLOCK AS BRIDGE TO URGENT PCI RESCUE 15
The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 Pandemic 15
Mental health status and sexual habits in young patient after acute coronary syndrome 15
Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality 14
A 4-item PRECISE-DAPT score for dual antiplatelet therapy duration decision-making 13
Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review 13
Echocardiographic Evolution of PosteroLateral Left Ventricular Aneurysm with Normal Coronary Arteries in Patient Recently COVID-19 Vaccinated: A Complicated Atypical Case of Takotsubo Syndrome Vaccine-related? 12
A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery Disease 12
A Very Late Atrial Septal Erosion After an Ostium Secundum Percutaneous Closure 11
Analysis of changes in "mitral valve reserve" after coronary artery bypass grafts in patients with functional mitral regurgitation 11
Antithrombotic Therapy in Acute Coronary Syndrome: Striking a Happy Medium 11
A Look Beyond Statins and Ezetimibe: a Review of Other Lipid-Lowering Treatments for Cardiovascular Disease Prevention in High-Risk Patients 10
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? A Pre-Specified Analysis from the ZEUS Trial 9
Chronic Thrombocytopenia and Percutaneous Coronary Intervention: The Virtue of Prudence ∗ 9
Characterization of the Individual Patient Risk After Percutaneous Coronary Intervention: At the Crossroads of Bleeding and Thrombosis 8
Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial 8
Distal radial artery access for percutaneous coronary intervention: Convincing the sceptical cardiologist 7
Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients 7
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials 6
How to fill the GAPS-I in secondary prevention: application of a strategy based on GLP1 analogues, antithrombotic agents, PCSK9 inhibitors, SGLT2 inhibitors and immunomodulators 6
Impact of Clinical Presentation on Ischemic and Bleeding Outcomes in Patients Receiving 6 or 24 Month Duration of Dual Antiplatelet Therapy After Stent Implantation: A Pre-Specified Analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) PRODIGY Trial 6
Myocardial ischemia due to a recanalized chronic coronary thrombus: Angiographic and optical coherence tomography imaging insights 6
Bleeding risk in patients undergoing percutaneous coronary intervention: how to define, identify and treat high-risk patients 6
“Ticagrelor or Prasugrel, Doctor?” The Basis for Decision in Clinical Practice 6
In-stent restenosis of superficial femoral artery: use all arrows in the quiver 5
Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials 5
Validation of the ARC-HBR criteria in 68,874 patients undergoing PCI: A systematic review and meta-analysis 5
DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients 4
The optimal duration of dual antiplatelet therapy after coronary stent implantation: To go too far is as bad as to fall short 4
New paradigm for the management of cardio-nephro-metabolic syndrome: multidisciplinary approach and role of telemedicine 4
null 4
Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease 4
Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial 3
Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management 2
External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis 2
Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 2
Aspirin-Free Strategy After ACS Implementing Colchicine: Looking for a Substitution? 1
One or 3 months dual antiplatelet therapy in high bleeding risk patients: splitting hair or aiming at the bullseye? 1
Effect of lipid-lowering therapy on platelet reactivity in patients treated with and without antiplatelet therapy 1
External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease 1
Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions 1
Spectral CT Imaging of Prosthetic Valve Embolization after Transcatheter Aortic Valve Implantation 1
Inhibidores selectivos de la recaptacion de serotonina y riesgo hemorragico tras ICP. Un estudio con puntuacion de propension 1
Totale 1.953
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.132
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201916 0 0 0 0 0 0 0 0 0 0 7 9
2019/2020145 39 2 2 13 8 29 18 4 4 7 13 6
2020/2021182 8 6 15 13 30 16 13 25 8 38 4 6
2021/2022207 2 15 15 6 4 8 19 3 5 39 23 68
2022/2023998 31 86 40 29 70 124 18 75 488 9 22 6
2023/2024316 21 27 17 39 24 73 70 16 7 21 1 0
Totale 1.953